drugset / Trial / NCT04491682
Megestrol Acetate Plus Rosuvastatin in Young Women With Atypical Endometrial Hyperplasia
NaSingle-groupOpen-labelTreatment
Summary
To see if megestrol acetate plus rosuvastatin will be superior to reversing the endometrial lesion to a normal endometrium than megestrol acetate alone in patients with atypical endometrial hyperplasia (AEH). Considering the large sample size in RCT, we used Simon two-stage design.
Timeline
- Start
- 2020-09-01
- Primary completion
- 2022-06-20
- Completion
- 2022-06-20
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Megestrol Acetate | Other / unclassified | 160 mg | Oral |
| Subject | Rosuvastatin | Small molecule | 10 mg | Oral |